Please login or register first to view this content.
OB/GYN Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
HIV Patient’s Detectable Viremia Linked to ART-Supplement Interaction
Merzee, a Generic Equivalent of Taytulla, Approved for Pregnancy Prevention
Oteseconazole Promising for Recurrent Vulvovaginal Candidiasis
Twirla Contraceptive Patch Now Available
Ibrexafungerp Gets Priority Review for Vulvovaginal Candidiasis
Hormonal Contraceptives Linked to Decline in Asthma Exacerbation
Hormonal Contraceptive Use May Delay Return of Fecundability
Secnidazole Under Review for Trichomoniasis
Generic Version of Oral Contraceptive Taytulla Gets Approval
FDA: NSAID Use Should Be Avoided in Pregnancy Even Sooner Than 30 Weeks
Ibrexafungerp NDA for Vulvovaginal Candidiasis Submitted for Review
FDA Proposes Makena Be Withdrawn From the Market
Modafinil in Early Pregnancy Not Tied to Congenital Malformations
Phexxi, a Vaginal pH Regulator, Now Available for Pregnancy Prevention
NAMS 2020 Genitourinary Syndrome of Menopause Position Statement Released
COVID-19 During Pregnancy May Pose Risks for Mother, Baby
Mirena Approved for Pregnancy Prevention for Up to 6 Years
FDA to Review Relugolix Combination Therapy for Uterine Fibroids